Anti-CD19:TCRζ CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CD19:TCRζ CAR-T cells, covering 2016-12-14 to 2016-12-14. Get the full timeline:
Most recent: Clinical Trial Update: Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma [Phase 4]